Religare Enterprises Grants 22,692 Stock Options Under Employee Stock Option Plan 2019

1 min read     Updated on 31 Mar 2026, 06:52 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Religare Enterprises Limited granted 22,692 stock options to eligible employees under its ESOP 2019 scheme, approved by the Nomination and Remuneration Committee on March 30, 2026. The options carry an exercise price of Rs. 220.34 per share and will vest over five years in equal 20% annual installments, with employees having up to eight years from vesting to exercise their options. This initiative demonstrates the company's commitment to employee retention and long-term incentive alignment.

powered bylight_fuzz_icon
36465731

*this image is generated using AI for illustrative purposes only.

Religare Enterprises Limited has granted 22,692 stock options to eligible employees under its Employee Stock Option Plan 2019, as approved by the company's Nomination and Remuneration Committee on March 30, 2026. This employee incentive initiative demonstrates the company's commitment to aligning workforce interests with long-term organizational growth.

Stock Option Grant Details

The comprehensive stock option grant encompasses several key parameters designed to provide structured employee benefits over an extended period.

Parameter Details
Total Options Granted 22,692 stock options
Eligible Recipients Company employees
Exercise Price Rs. 220.34 per equity share
Face Value per Share Rs. 10.00
Conversion Ratio 1 option = 1 equity share

Vesting Schedule and Timeline

The stock options follow a structured five-year vesting schedule, ensuring gradual benefit realization and employee retention. The vesting occurs in equal annual installments, with each tranche representing 20% of the total grant.

Vesting Year Options to Vest Percentage
1st Year 4,538 options 20%
2nd Year 4,538 options 20%
3rd Year 4,538 options 20%
4th Year 4,538 options 20%
5th Year 4,540 options 20%

The first vesting installment will occur upon completion of one year from the grant date, establishing a clear timeline for employee benefit realization.

Exercise Terms and Regulatory Compliance

Employees will have up to eight years from the respective vesting dates to exercise their stock options, providing flexibility in timing their equity participation. The scheme operates in full compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, having received approval from both the Board of Directors and shareholders.

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in its employee benefit programs. As the options have not yet been exercised, no diluted earnings per share impact has occurred at this time.

Strategic Employee Incentive Initiative

This stock option grant represents Religare Enterprises' ongoing effort to attract and retain talent through equity-based compensation. The structured vesting schedule and extended exercise period provide employees with long-term incentive alignment, encouraging continued contribution to company success over multiple years.

Historical Stock Returns for Religare Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+1.98%-1.17%+5.67%-10.61%-1.89%+135.79%

How will the potential dilution from these 22,692 stock options impact Religare's earnings per share when employees begin exercising them over the next few years?

What does this employee stock option grant signal about Religare's talent retention challenges and future hiring plans in the competitive financial services sector?

Will Religare need to expand this ESOP program further if the company pursues aggressive growth strategies or faces increased competition for skilled employees?

Religare Enterprises Receives Bombay High Court Stay Order on GST Demand for Subsidiary Care Health Insurance

2 min read     Updated on 31 Mar 2026, 03:41 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Religare Enterprises' material subsidiary Care Health Insurance Limited received a stay order from Bombay High Court on March 26, 2026, regarding a GST demand of Rs. 17,68,26,837 plus equal penalty for FY 2017-18 to 2023-24 SEZ matters. The stay remains effective until final disposal of the writ petition, providing temporary relief from the substantial financial demand raised by GST authorities in Faridabad.

powered bylight_fuzz_icon
36454285

*this image is generated using AI for illustrative purposes only.

Religare Enterprises Limited has informed stock exchanges that its material subsidiary Care Health Insurance Limited (CHIL) has received a favorable stay order from the Hon'ble Bombay High Court regarding a significant GST demand matter. The development provides temporary relief to the subsidiary in a case involving substantial financial implications.

Court Stay Order Details

The Hon'ble Bombay High Court issued the stay order on March 26, 2026, which CHIL received through its tax advisors on March 28, 2026. The stay order pertains to a writ petition filed against the original order issued by the Office of the Assistant Commissioner of Goods and Services Tax, Faridabad.

Parameter: Details
Court: Hon'ble Bombay High Court
Order Date: March 26, 2026
Receipt Date by CHIL: March 28, 2026
Receipt Date by REL: March 30, 2026
Status: Stay granted till final disposal

GST Demand and Penalty Structure

The original order from the GST authorities covers the period from FY 2017-18 to 2023-24 and relates to SEZ (Special Economic Zone) matters. The financial implications are substantial, involving both demand and penalty components.

Component: Amount (Rs.)
GST Demand: 17,68,26,837
Interest: As per sections 50 of CGST Act & 20 of IGST Act
Penalty: 17,68,26,837
Legal Basis: Sections 74 and 122 of CGST Act, 2017

Regulatory Compliance and Impact

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This follows an earlier announcement made on February 04, 2025, regarding the same matter.

Key regulatory details include:

  • The matter involves industry-wide issues affecting multiple entities
  • The applicable period spans from July 2017 to March 2024
  • Currently, there is no financial impact at this stage due to the stay order
  • No immediate penalties or restrictions are imposed pursuant to the court communication

Corporate Structure Context

Care Health Insurance Limited operates as a material subsidiary of Religare Enterprises Limited, the listed entity. The parent company has taken appropriate steps to inform stakeholders about developments affecting its subsidiary, maintaining transparency in corporate governance and regulatory compliance.

The stay order provides breathing room for CHIL to contest the GST demand through proper legal channels while business operations continue without immediate financial burden from the disputed amount.

Historical Stock Returns for Religare Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+1.98%-1.17%+5.67%-10.61%-1.89%+135.79%

How might the final court ruling on this GST matter impact Care Health Insurance's expansion plans and capital allocation strategy?

Will this industry-wide SEZ-related GST dispute lead to regulatory clarifications that could affect other insurance companies' tax liabilities?

What contingency funding arrangements has Religare Enterprises put in place if the court ultimately upholds the Rs 35+ crore GST demand and penalty?

More News on Religare Enterprises

1 Year Returns:-1.89%